ArticleJournal of clinical immunology2021
Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation.
Basak Kayaoglu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it